Megan Lee

We are thrilled to announce the launch of our new Micro-certificate in Innovation Leadership: Medical & Bio-Innovations! 🎓✨ This program wouldn't have been possible without the incredible support and insights from our industry advisory committee and partners at the UBC Academy of Translational Medicine and UBC Extended Learning. Together, we've crafted a curriculum designed to meet the needs of the bioeconomy, ensuring participants gain the practical legal and strategic skills needed to bring scientific and technical innovations to market. This includes mastering effective IP strategies and identifying market gaps and addressing unmet healthcare needs. 🔬 Why This Program? As Canada's life sciences sector experiences unprecedented growth, the demand for skilled professionals who can successfully translate biomedical innovations from lab to market is more critical than ever. This part-time program offers a comprehensive understanding of the legal, technical, and market realities that influence the development and commercialization of new products and treatments. Through real-life case studies and instruction from industry experts, the program provides relevant, in-demand leadership and business skills needed to identify and act on future opportunities. A huge thank you to Novateur Ventures Inc. and all our industry collaborators who contributed to making this program a reality. Their insights have been invaluable in crafting a curriculum that not only addresses the immediate needs of the industry but also anticipates future trends. Participants will benefit from this deep industry engagement, gaining practical knowledge and strategies that are immediately applicable in their professional roles. To learn more and register, please visit: https://lnkd.in/gN3eeFWx Jonathon Jafari | entrepreneurship@UBC

32

Discover the vital role of Health Technology Assessment (HTA) in shaping Canada's healthcare decisions! 📊✨ Join us as we explore HTA's impact on funding, policy-making, and patient care through evidence-based evaluations. Watch now to learn how HTA drives informed, quality-focused healthcare. 🌍🏥 For more insights, read the full research paper and contact us to involve patients in HTA development here: Lopes, E., Street, J., Carter, D., Merlin, T., & Stafinski, T. (2020). Understanding Canadian Health Technology Assessment through a systems lens #HealthTechnologyAssessment #HTA #HealthcareFunding #EvidenceBased #TransparentMethods #HealthcareCanada #HTAExperts #HealthInnovation #HealthcareImprovement #ContactUs #HealthcareSupport #HealthTech #MedicalResearch #ContinuousImprovement #HTAServices #Canada

13

The FDA will soon require Diversity Action Plans for certain clinical trials. UBC’s expert strategy planning team can help make sure you are ready. Read our white paper for guidance on diversity action planning: https://hubs.li/Q02Q8gvy0 #PatientsFirst #DiversityInClinicalTrials #RWE #RealWorldEvidence #RWD #RealWorldData

15

Press Release: Ontario Unveils Groundbreaking Digital Health Projects as a Result of the Innovating Digital Health Solutions Program Achieving Over $3 million in Cost Savings We’re proud to be supporting one of the projects selected by the Ontario Centre of Innovation (OCI) as part of the Innovating Digital Health Solutions (IDHS) program, an initiative funded by the Ontario Government | Gouvernement de l’Ontario. Since the project began, we’ve been working with the Grey-Bruce Ontario Health Team (OHT) and Brightshores Health System to support a standardized Measurement-Based Care implementation across more than 8 community health organizations in the Grey-Bruce region, including over 100 mental health providers. The goal has been to improve data-driven decision-making and client engagement at a large-scale, in order to unlock invaluable insights into the region's healthcare landscape that can inform continuous innovation in care delivery and overall service quality improvement. Thank you OCI, Grey-Bruce OHT, and Brightshores for collaborating with us on this initiative. We’re excited to continue our partnership efforts across Grey-Bruce to meaningfully improve and integrate community healthcare. To learn more about the IDHS program and its impact, read the press release: https://ow.ly/WHlT50StI3j #IntegratedHealth #MeasurementBasedCare #MBC #Outcomes

27

2 Comments

Registration for the 16th Canadian Science Policy Conference #CSPC2024 is OPEN! https://lnkd.in/gMmS82c With the overarching theme of ‘Empowering Society: The Transformative Value of Science, Knowledge, and Innovation’ CSPC 2024 expects more than 1000 participants, 300+ speakers in 50+ panel sessions. Conference tracks: ➡️Science, Knowledge, and Policy ➡️Science, Knowledge, and Society ➡️Innovation Policy and Economic Development ➡️Science, International Affairs and Security ➡️Science and the Next Generation ➡️Grand Challenges #CdnSci #CdnInnovation #SciencePolicy #Innovation

4

Our upcoming Angel Investing 101 session, Angel Investing in MedTech: Insights and Strategies for Navigating the Biotech Landscape, will be presented by Nick Kuryluk, OBIO and Canadian Stem Cell Network medtech pitch assessor and commercialization trainer, pitch panelist at Altitude Accelerator, and member of the Brampton Angels. 🌟 This session will provide angel investors with a comprehensive overview of the medtech landscape, covering key trends, market opportunities, and the unique challenges of investing in this sector. The presentation will dive into essential components from innovation to commercialization, including: - Technology & Clinical Validation, - Regulatory Pathways & Reimbursement Complexities - Market Access Concluding with actionable takeaways, the session will equip investors with the tools needed to evaluate and support medtech innovations effectively. 🚀 Register here: https://hubs.ly/Q02WGdwJ0

6

The decades-long trend of disinvestment in healthcare infrastructure has led to unacceptable barriers to access and serious challenges to the quality of care Canadians receive. Addressing these issues can seem dauntingly complex; before adopting new policies, it’s important to make sure remedies are well designed to achieve a return on investment. In determining the most impactful ways to move forward, the government and other key players in Canada’s healthcare system can look to other countries whose healthcare systems are particularly effective on a given measure and take a page from those countries’ playbook. 🔗 Read the full story on The Gryphon Group Blog: https://lnkd.in/gB6VyQun #healthcarenews #healthcareindustry #canadianhealth #healthcanada #healthcaresystems #TheGryphonGroup

6

The Pandemic was a real education to Canada, and it's reliance on technologies and companies outside this country. When push came to shove, and the world was competitng for valuable resources to test for Covid, Canada was left out in the cold (literally). We had no access to extraction technologies, and no vaccine capabilities ourselves. DMark Biosciences played a pivotal role in supplying Canada with RNA extraction instrumentation and kits. Our partners of Revvity, MolGen, and Complete Genomics provided instrumentation and kits throughout Canada, where traditional suppliers refused to sell to Canada. Now that Canada is gearing up its vaccine response for the next pandemic, @DMark is here to help again. We have partnered with L7 Informatics for over a decade providing the best Enterprise Science platform available on the planet to manage the data required to enable biomanufacturing. This webinar will help you learn how L7/ESP will speed the time to market for Drugs from development to commercialization, Reduce costs and improve operational efficiencies, and provide a single source of truth for scientific data and process management throughout the product lifecycle management. Whether your field is protein, genomics, multi-omics, research, diagnostics, development or manufacturing, L7 will provide huge value for your scientific life sciences data management.

16

3 Comments